Healthcare technology company Abbott has been granted Conformité Européene approval for its Merlin RX ICM cardiac device . The device is inserted into the patient’s chest by a physician. The device , which weighs three grams and is less than two inches long , is inserted into a patient 's heart by a surgeon and wirelessly transmits continuous , encrypted data via an interface to the Merlin.net Patient Care Network . The Confirm RX ICM will be launched during Q2 2017 . The device is currently awaiting the approval of the US Food and Drug Administration .
Healthcare technology company Abbott has been granted Conformité Européene approval for its Merlin RX ICM cardiac device . The device , which weighs three grams and is less than two inches long , is inserted into a patient 's heart by a surgeon and wirelessly transmits continuous , encrypted data via an interface to the Merlin.net Patient Care Network . The Confirm RX ICM will be launched during Q2 2017 . The device is currently awaiting the approval of the US Food and Drug Administration .